PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Training and Education Department, President of Ozone Forum of India, Mumbai, India.\', \'Head of the Clinical Department, Director of Ozone Forum of India, Mumbai, India.\', \'Trustee in Department of Ozone Therapy, Lokmanya Medical Research Centre, Pune, India. Electronic address: vgvaidya178@gmail.com.\', \'Department of Oncology, Integrated Cancer Treatment and Research Centre, Wagholi, Pune, India.\', \'Department of Ozone Therapy, Lokmanya Medical Research Centre, Pune, India.\', \'Indian Academy for Scientific Writing and Research, Pune, India. Electronic address: director@iaswar.com.\', \'Clinical Research, Department of Ozone Therapy, Lokmanya Medical Research Centre, Pune, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(20)33768-110.1016/j.intimp.2020.107301
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33421928
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
?:title
  • Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study).
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33421928>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33421928>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all